148 related articles for article (PubMed ID: 10675411)
21. The relative amount of an influenza A virus segment present in the viral particle is not affected by a reduction in replication of that segment.
Bergmann M; Muster T
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3211-5. PubMed ID: 8847532
[TBL] [Abstract][Full Text] [Related]
22. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
23. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation.
Chen J; Fang F; Li X; Chang H; Chen Z
Vaccine; 2005 Jul; 23(34):4322-8. PubMed ID: 15925433
[TBL] [Abstract][Full Text] [Related]
24. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.
Mitnaul LJ; Castrucci MR; Murti KG; Kawaoka Y
J Virol; 1996 Feb; 70(2):873-9. PubMed ID: 8551626
[TBL] [Abstract][Full Text] [Related]
25. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
Lu B; Zhou H; Ye D; Kemble G; Jin H
J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
[TBL] [Abstract][Full Text] [Related]
26. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
27. Biologic importance of neuraminidase stalk length in influenza A virus.
Castrucci MR; Kawaoka Y
J Virol; 1993 Feb; 67(2):759-64. PubMed ID: 8419645
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase.
Castrucci MR; Bilsel P; Kawaoka Y
J Virol; 1992 Aug; 66(8):4647-53. PubMed ID: 1378505
[TBL] [Abstract][Full Text] [Related]
29. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of influenza A virus mRNA levels by promoter mutations.
Fodor E; Palese P; Brownlee GG; García-Sastre A
J Virol; 1998 Aug; 72(8):6283-90. PubMed ID: 9658066
[TBL] [Abstract][Full Text] [Related]
31. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
32. The position 4 nucleotide at the 3' end of the influenza virus neuraminidase vRNA is involved in temporal regulation of transcription and replication of neuraminidase RNAs and affects the repertoire of influenza virus surface antigens.
Lee KH; Seong BL
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1923-34. PubMed ID: 9714240
[TBL] [Abstract][Full Text] [Related]
33. N-Linked Glycosylation Plays an Important Role in Budding of Neuraminidase Protein and Virulence of Influenza Viruses.
Bao D; Xue R; Zhang M; Lu C; Ma T; Ren C; Zhang T; Yang J; Teng Q; Li X; Li Z; Liu Q
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177197
[TBL] [Abstract][Full Text] [Related]
34. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
[TBL] [Abstract][Full Text] [Related]
35. Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice.
Pu J; Wang J; Zhang Y; Fu G; Bi Y; Sun Y; Liu J
Virus Res; 2010 Aug; 151(2):200-4. PubMed ID: 20546807
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of and immunity to avian influenza A H5 viruses.
Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
[TBL] [Abstract][Full Text] [Related]
37. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
[TBL] [Abstract][Full Text] [Related]
38. An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice.
Muster T; Subbarao EK; Enami M; Murphy BR; Palese P
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5177-81. PubMed ID: 2052599
[TBL] [Abstract][Full Text] [Related]
39. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
Ze C; Kurata T; Tamura S
Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
[TBL] [Abstract][Full Text] [Related]
40. A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice.
Hrincius ER; Hennecke AK; Gensler L; Nordhoff C; Anhlan D; Vogel P; McCullers JA; Ludwig S; Ehrhardt C
Am J Pathol; 2012 Jun; 180(6):2361-74. PubMed ID: 22525464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
